Introduction: Peripartum hysterectomy is usually undertaken in cases of life-threatening obstetric hemorrhage to prevent the death of the mother. Near-miss events are still under-researched and inappropriate care continues to be a critical issue, even in countries with advanced obstetric surveillance systems. The aim of the present study was to estimate the prevalence, associated factors, management and intraoperative and postoperative complications of peripartum hysterectomy due to obstetric hemorrhage.

Material And Methods: A prospective population-based study has been conducted in six Italian regions covering 49% of births in Italy. The study population comprised all women aged 11-59 years undergoing peripartum hysterectomy, from September 2014 to August 2016, due to obstetric hemorrhage within 7 days of delivery. In each maternity unit a trained reference person reported incident cases using electronic data collection forms. The background population comprised all women who delivered in the participating regions during the study period.

Results: The overall peripartum hysterectomy prevalence was 1.09 per 1000 maternities, with a large variability among regions, ranging from 0.52 to 1.60. Previous cesarean section (relative risk [RR] 4.97, 95% CI 4.13-5.96), assisted reproductive technology (RR 5.99, 95% CI 4.42-8.11) multiple pregnancy (RR 5.03, 95% CI 3.57-7.09) and maternal age ≥35 years (RR 2.69, 95% CI 2.25-3.21) were the main associated factors for hysterectomy. The most common causes of peripartum hysterectomy were uterine atony (45.1%) and abnormally invasive placentation (40.2%). Intensive care unit admission was reported in 49.9% of cases, 16.8% of women suffered severe morbidity and 5 women died.

Conclusions: The rate of peripartum hysterectomy in Italy was three times higher compared with the UK, the Netherlands and the Nordic countries. The wide difference may be associated with women's characteristics, such as age at delivery and previous cesarean section, and with different management options leading to peripartum hysterectomy.

Download full-text PDF

Source
http://dx.doi.org/10.1111/aogs.13727DOI Listing

Publication Analysis

Top Keywords

peripartum hysterectomy
32
obstetric hemorrhage
12
hysterectomy
9
peripartum
8
undergoing peripartum
8
hysterectomy obstetric
8
prospective population-based
8
population-based study
8
associated factors
8
population comprised
8

Similar Publications

Background: Placenta accreta spectrum (PAS) disorder is a fatal condition responsible for obstetric haemorrhage, which contributes to increased feto-maternal morbidity and mortality. The main contributing factor is a scarred uterus, often from a previous cesarean delivery, myomectomy, or uterine instrumentation. The occurrence of PAS in an unscarred uterus is extremely rare, with only anecdotal cases reported so far in the literature.

View Article and Find Full Text PDF

Transcriptomic analysis identified novel biomarker in invasive placenta accreta spectrum.

Placenta

December 2024

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China; National Clinical Research Center for Obstetrics and Gynecology (Peking University Third Hospital), Beijing, 100191, China; State Key Laboratory of Female Fertility Promotion, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China; Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, 100191, China; Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, 100191, China. Electronic address:

Article Synopsis
  • - Placenta accreta spectrum (PAS) disorders significantly endanger maternal health due to risks of severe bleeding and the necessity for hysterectomy, highlighting the need for reliable biomarkers.
  • - This study identified miR-23a-5p as a potentially valuable biomarker for PAS through RNA-seq and qRT-PCR analysis, showing it is down-regulated in PAS cases while its target genes ASF1B and CHTF8 are up-regulated.
  • - Combining miR-23a-5p with CHTF8 enhances diagnostic accuracy for PAS and related adverse outcomes, with improved AUC values suggesting their effectiveness as novel biomarkers.
View Article and Find Full Text PDF

We present a rare case report of a patient with a congenital uterine anomaly - uterus didelphys. Who spontaneously became pregnant and completed the pregnancy successfully after peripartum hysterectomy of one uterus. The reason for the peripartum hysterectomy was a life-threatening hemorrhage with hemoperitoneum after cesarean delivery.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare maternal morbidity and prenatal characteristics between two groups of women with placenta percreta: those with extrauterine disease (group B) and those with disease confined to the uterus (group A).
  • A total of 73 cases were analyzed, revealing significantly higher blood loss, injury rates, and complications in group B compared to group A, highlighting the increased risks associated with extrauterine disease.
  • The findings suggest that specialized care for placenta accreta spectrum (PAS) is essential, as cases with extrauterine disease are more complex and lead to higher maternal morbidity, indicating a need for differentiation in treatment approaches.
View Article and Find Full Text PDF

Background: Anticoagulant therapy prevents thrombosis and thromboembolic events in patients with mechanical heart valves. Bridging anticoagulation around the time of birth represents a unique challenge. Few retrospective reviews or case series exist examining peripartum outcomes with bridging anticoagulation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!